⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001932215

Gallagher Patrick Stephen

Reports to the SEC for 1 company · BOSTON, MA

Transactions

8

Companies

1

Filings

4

CIK

0001932215

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Chief Business Officer	AAward	+29.3K sh	—	—	29,313
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Chief Business Officer	AAward	+14.2K sh	—	—	43,513
2023-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+60K sh	—	—	60,000
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Chief Business Officer	AAward	+29.3K sh	—	—	29,313
2023-02-15	FTHFaeth Therapeutics, Inc.A Award	Chief Business Officer	AAward	+14.2K sh	—	—	43,515
2023-02-15	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+60K sh	—	—	60,000
2023-02-15	FTHFaeth Therapeutics, Inc.F Tax Payment	Chief Business Officer	FTax Payment	−9,383 sh	$1.50	−$14.1K	34,130
2022-06-01	FTHFaeth Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+150K sh	—	—	150,000

Recent filings

4

Accepted (ET)
Sep 114
Gallagher Patrick Stephen0001209191-23-048968
SEC(opens sec.gov)
Mar 294/A
Gallagher Patrick Stephen0001209191-23-021540
SEC(opens sec.gov)
Feb 174
Gallagher Patrick Stephen0001209191-23-010734
SEC(opens sec.gov)
Jun 34
Gallagher Patrick Stephen0001209191-22-034040
SEC(opens sec.gov)

Companies

1

Faeth Therapeutics, Inc.Chief Business OfficerFTH

Address

C/O SENSEI BIOTHERAPEUTICS, INC. 451 D STREET, SUITE 710

BOSTON, MA, 02210